Application

TALTZ

Eli Lilly and Company

Trademark/Service Mark Application, Principal Register

PTO Form 1478 (Rev 9/2006)
OMB No. 0651-0009 (Exp 12/31/2011)

Trademark/Service Mark Application, Principal Register

Serial Number: 85476614
Filing Date: 11/18/2011

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 85476614
MARK INFORMATION
*MARK TALTZ
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT TALTZ
MARK STATEMENT The mark consists of standard characters, without claim to any particular font, style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Eli Lilly and Company
*STREET Lilly Corporate Center
*CITY Indianapolis
*STATE
(Required for U.S. applicants)
Indiana
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. applicants only)
46285
PHONE 317-276-9624
FAX 317-276-1919
EMAIL ADDRESS XXXX
WEBSITE ADDRESS www.lilly.com
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION Indiana
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; antidepressants; veterinary preparations
FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
MISCELLANEOUS STATEMENT The mark is a coined, non-dictionary word with no English translation.
ATTORNEY INFORMATION
NAME Robert E. Lee, Jr.
FIRM NAME Eli Lilly and Company
STREET Lilly Corporate Center
CITY Indianapolis
STATE Indiana
COUNTRY United States
ZIP/POSTAL CODE 46285
PHONE 317-276-9624
FAX 317-276-1919
EMAIL ADDRESS trademarks@lilly.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Bruce W. Longbottom, Lawrence T. Welch, and Douglas K. Norman
CORRESPONDENCE INFORMATION
NAME Robert E. Lee, Jr.
FIRM NAME Eli Lilly and Company
STREET Lilly Corporate Center
CITY Indianapolis
STATE Indiana
COUNTRY United States
ZIP/POSTAL CODE 46285
PHONE 317-276-9624
FAX 317-276-1919
EMAIL ADDRESS trademarks@lilly.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
NUMBER OF CLASSES 1
FEE PER CLASS 325
*TOTAL FEE DUE 325
*TOTAL FEE PAID 325
SIGNATURE INFORMATION
SIGNATURE /reljr44/
SIGNATORY'S NAME Robert E. Lee, Jr.
SIGNATORY'S POSITION Assistant General Patent Counsel
DATE SIGNED 11/18/2011



PTO Form 1478 (Rev 9/2006)
OMB No. 0651-0009 (Exp 12/31/2011)


Trademark/Service Mark Application, Principal Register

Serial Number: 85476614
Filing Date: 11/18/2011

To the Commissioner for Trademarks:

MARK: TALTZ (Standard Characters, see mark)
The literal element of the mark consists of TALTZ.
The mark consists of standard characters, without claim to any particular font, style, size, or color.

The applicant, Eli Lilly and Company, a corporation of Indiana, having an address of
      Lilly Corporate Center
      Indianapolis, Indiana 46285
      United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; antidepressants; veterinary preparations
Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or services. (15 U.S.C. Section 1051(b)).


The mark is a coined, non-dictionary word with no English translation.

For informational purposes only, applicant's website address is: www.lilly.com

The applicant's current Attorney Information:
Robert E. Lee, Jr. and Bruce W. Longbottom, Lawrence T. Welch, and Douglas K. Norman of Eli Lilly and Company
      Lilly Corporate Center
      Indianapolis, Indiana 46285
      United States


The applicant's current Correspondence Information:
      Robert E. Lee, Jr.
      Eli Lilly and Company
      Lilly Corporate Center
      Indianapolis, Indiana 46285
      317-276-9624(phone)
      317-276-1919(fax)
      trademarks@lilly.com (authorized)

A fee payment in the amount of $325 has been submitted with the application, representing payment for 1 class(es).

Declaration

The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements, and the like, may jeopardize the validity of the application or any resulting registration, declares that he/she is properly authorized to execute this application on behalf of the applicant; he/she believes the applicant to be the owner of the trademark/service mark sought to be registered, or, if the application is being filed under 15 U.S.C. Section 1051(b), he/she believes applicant to be entitled to use such mark in commerce; to the best of his/her knowledge and belief no other person, firm, corporation, or association has the right to use the mark in commerce, either in the identical form thereof or in such near resemblance thereto as to be likely, when used on or in connection with the goods/services of such other person, to cause confusion, or to cause mistake, or to deceive; and that all statements made of his/her own knowledge are true; and that all statements made on information and belief are believed to be true.


Signature: /reljr44/   Date Signed: 11/18/2011
Signatory's Name: Robert E. Lee, Jr.
Signatory's Position: Assistant General Patent Counsel



RAM Sale Number: 1867
RAM Accounting Date: 11/21/2011

Serial Number: 85476614
Internet Transmission Date: Fri Nov 18 15:19:25 EST 2011
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XX-20111118151925422
361-85476614-4806481fdd7e1d644c3201e862f
852ec3d5-DA-1867-20111118141258702589

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed